YGE [YINGLI GREEN ENERGY] UPLOAD: (Original Filing)
[]
[SCHEDULE 13D/A (Amendment No 1) Biostar Pharmaceuticals, (Name of Issuer)mmon Stock (Title of Class of Securities) 090678103 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) November 18, 2009 (Date of Event which Requires Filing of this Statement) If]
[YEAR 2009 / 3 rd QUARTER The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater China to the world, using a] [GLOBAL SOURCES LTD. AND SUBSIDIARIES At At September 30, December 31, 2009 2008 (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 88,821 $ 70,225 Term deposits with banks 60,088 Available-for-sale securities 6,337 60,786 Accounts receivable, net 3,870 6,025 Receivables from sales representatives 8,076 5,574 Inventory 650 1,306 Prepaid expenses and other current assets]
[YEAR 2009 / 3 rd QUARTER The following discussion of our financial condition and results of operations should be read in conjunction with the accompanying financial statements. Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater China to the world, using a] [GLOBAL SOURCES LTD. AND SUBSIDIARIES At At September 30, December 31, 2009 2008 (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 88,821 $ 70,225 Term deposits with banks 60,088 Available-for-sale securities 6,337 60,786 Accounts receivable, net 3,870 6,025 Receivables from sales representatives 8,076 5,574 Inventory 650 1,306 Prepaid expenses and other current assets]